Seattle Children's Research Institute: Jack R Macdonald Building

bluebird bio Inc., located in Seattle, WA, is dedicated to developing curative gene therapies aimed at providing patients and their families with improved quality of life. With a focus on conditions such as beta-thalassemia, cerebral adrenoleukodystrophy, and sickle cell disease, the company has established itself as a leader in the field of gene therapy through innovative approaches and extensive research. For over a decade, bluebird bio has been at the forefront of advancing gene therapies, utilizing proprietary lentiviral vector technology to deliver functional gene copies to patients' cells. Committed to collaboration and ethical practices, the company strives to set new standards in gene therapy, all while emphasizing the importance of patient advocacy and support. Generated from the website